emcellschina.com ). Many of these conditions are still deemed
untreatable using conventional medical techniques and account for an
estimated 60% of gross mortality worldwide. While not currently possible,
scientists in labs like the one being established in Shenzhen are narrowing
in on the technology that may soon allow for the reprogramming of human
body cells. This would allow for the potential to regenerate nerve cells to
heal spinal cord injuries, create one's own pancreatic cells to stop
diabetes, or possibly generate cells of any other tissue type to treat
whatever ails patients. This makes the successful application of stem cells
of vital significance to human health and the medical field.
About Beike Biotechnology Company Limited
Beike is a biotechnology company that was founded in July 2005 with
capital from Beijing University, Hong Kong University of Science and
Technology and Shenzhen City Hall when it commercialized stem cell
technology that had been in research since 1999. A s a private high-tech
enterprise, it is dedicated to the clinical application of stem cell
research. It is also supported with funds from the China State National
Fund. The research and clinical work is a collaboration of Beijing
University, Hong Kong University of Science and Technology, No. 3 Army
Medical University, Zhongshan Medical University, Guiyang Medical College
and Zhengzhou University.
About The Graduate School at Shenzhen, Tsinghua University
The Graduate School of Tsinghua University in Shenzhen is an institute
jointly established by Shenzhen City Hall and Tsinghua University to
provide training for talent at the postgraduate level in science and
technical innovation. The Graduate School of Tsinghua in Shenzhen is
committed to the integration of teaching, research, and rapid
commercialization of scientific discovery.
For more information, please contact:
Jonathan Hakim
Beike Biotech Company, Ltd.
Shenzhen Hi-Tech
'/>"/>
SOURCE Beike Biotech Company, Ltd. Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
DuPont Leaders Brief Investors on Agriculture Businesses2.
Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion3.
N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation4.
Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry5.
United BioSource Acquires Caro Research, Leader in Simulation Modeling6.
KGI and Smith College Establish Leadership Forum for Women in Bioscience7.
RF Pain Management Industry Leaders Cotop International and NeuroTherm, Inc. Agree to Merge8.
Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference9.
Assay Designs(TM) Announces Additions to the Leadership Team10.
Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies11.
2007 Global Survey Identifies Characteristics of Supply Chain Leaders